“Cerovive, given by an infusion over 72 hours, traps free radicals – highly reactive molecules that can cause cell damage. The drug will not save the brain cells immediately downstream of a clot, which quickly die from lack of oxygen. It is meant instead to counter damage over a wider area of the brain that can occur in the days following a stroke.” (New York Times )